Perfusion Imaging and Clinical Outcome in Acute Ischemic Stroke with Large Core.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
09 2021
Historique:
revised: 28 06 2021
received: 02 04 2021
accepted: 28 06 2021
pubmed: 4 7 2021
medline: 9 11 2021
entrez: 3 7 2021
Statut: ppublish

Résumé

Mechanical thrombectomy (MT) is not recommended for acute stroke with large vessel occlusion (LVO) and a large volume of irreversibly injured tissue ("core"). Perfusion imaging may identify a subset of patients with large core who benefit from MT. We compared two cohorts of LVO-related patients with large core (>50 ml on diffusion-weighted-imaging or CT-perfusion using RAPID), available perfusion imaging, and treated within 6 hours from onset by either MT + Best Medical Management (BMM) in one prospective study, or BMM alone in the pre-MT era from a prospective registry. Primary outcome was 90-day modified Rankin Scale ≤2. We searched for an interaction between treatment group and amount of penumbra as estimated by the mismatch ratio (MMRatio = critical hypoperfusion/core volume). Overall, 107 patients were included (56 MT + BMM and 51 BMM): Mean age was 68 ± 15 years, median core volume 99 ml (IQR: 72-131) and MMRatio 1.4 (IQR: 1.0-1.9). Baseline clinical and radiological variables were similar between the two groups, except for a higher intravenous thrombolysis rate in the BMM group. The MMRatio strongly modified the clinical outcome following MT (p Perfusion imaging may help select which patients with large core should be considered for MT. Randomized studies are warranted. ANN NEUROL 2021;90:417-427.

Identifiants

pubmed: 34216396
doi: 10.1002/ana.26152
doi:

Types de publication

Clinical Trial Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-427

Investigateurs

François Chollet (F)
Louis Fontaine (L)
Marianne Barbieux (M)
Caterina Michelozzi (C)
Philippe Tall (P)
François Caparros (F)
Brigitte Pouzet (B)
Fabienne Calvas (F)
Monique Galitzki (M)
Amel Drif (A)
Pauline Renou (P)
François Rouanet (F)
Jerome Berge (J)
Gauthier Marnat (G)
Patrice Menegon (P)
Ludovic Lucas (L)
Cyrielle Coignon (C)
Sharmila Sagnier (S)
Sabrina Debruxelle (S)
Sylvain Ledure (S)

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 American Neurological Association.

Références

Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg 2019;11:535-538.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46-e110.
Xie Y, Oppenheim C, Guillemin F, et al. Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy. Ann Neurol 2018;83:178-185.
Campbell BCV, Majoie C, Albers GW, et al. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol 2019;18:46-55.
Rebello LC, Bouslama M, Haussen DC, et al. Endovascular treatment for patients with acute stroke who have a large ischemic core and large mismatch imaging profile. JAMA Neurol 2017;74:34-40.
Kerleroux B, Janot K, Dargazanli C, et al. Perfusion imaging to select patients with large ischemic core for mechanical thrombectomy. J Stroke 2020;22:225-233.
Sarraj A, Hassan AE, Savitz S, et al. Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: a secondary analysis of the optimizing patient's selection for endovascular treatment in acute ischemic stroke (SELECT) study. JAMA Neurol 2019;76:1147-1156.
Kakita H, Yoshimura S, Uchida K, et al. Impact of endovascular therapy in patients with large ischemic core: subanalysis of recovery by endovascular salvage for cerebral ultra-acute embolism Japan Registry 2. Stroke 2019;50:901-908.
Mourand I, Abergel E, Mantilla D, et al. Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation stroke. J Neurointerv Surg. 2018;10:5-9.
Gautheron V, Xie Y, Tisserand M, et al. Outcome after reperfusion therapies in patients with large baseline diffusion-weighted imaging stroke lesions: a THRACE trial (mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke) subgroup analysis. Stroke 2018;49:750-753.
Olivot JM, Albucher JF, Guenego A, et al. Mismatch profile influences outcome after mechanical thrombectomy. Stroke 2021;52:232-240.
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285-2295.
Tisserand M, Turc G, Charron S, et al. Does diffusion lesion volume above 70 mL preclude favorable outcome despite post-thrombolysis recanalization? Stroke 2016;47:1005-1011.
Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009-1018.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708-718.
Román LS, Menon BK, Blasco J, et al. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data. Lancet Neurol 2018;17:895-904.
Campbell BC, Christensen S, Parsons MW, et al. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol 2013;73:510-519.
Heit JJ, Mlynash M, Christensen S, et al. What predicts poor outcome after successful thrombectomy in late time windows? J Neurointerv Surg. 2020;13:421-425.
Hao Y, Liu W, Wang H, et al. Prognosis of asymptomatic intracranial hemorrhage after endovascular treatment. J Neurointerv Surg. 2019;11:123-126.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11-21.
Lin L, Bivard A, Levi CR, Parsons MW. Comparison of computed tomographic and magnetic resonance perfusion measurements in acute ischemic stroke: back-to-back quantitative analysis. Stroke 2014;45:1727-1732.
d'Esterre CD, Boesen ME, Ahn SH, et al. Time-dependent computed tomographic perfusion thresholds for patients with acute ischemic stroke. Stroke 2015;46:3390-3397.
Qiu W, Kuang H, Lee TY, et al. Confirmatory study of time-dependent computed tomographic perfusion thresholds for use in acute ischemic stroke. Stroke 2019;50:3269-3273.
Bivard A, Kleinig T, Miteff F, et al. Ischemic core thresholds change with time to reperfusion: a case control study. Ann Neurol 2017;82:995-1003.
Laredo C, Renú A, Tudela R, et al. The accuracy of ischemic core perfusion thresholds varies according to time to recanalization in stroke patients treated with mechanical thrombectomy: a comprehensive whole-brain computed tomography perfusion study. J Cereb Blood Flow Metab 2020;40:966-977.
Austein F, Riedel C, Kerby T, et al. Comparison of perfusion CT software to predict the final infarct volume after thrombectomy. Stroke 2016;47:2311-2317.

Auteurs

Pierre Seners (P)

Neurology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.
Neurology Department, Hôpital Fondation A. de Rothschild, Paris, France.

Catherine Oppenheim (C)

Radiology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.

Guillaume Turc (G)

Neurology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.

Jean-François Albucher (JF)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Adrien Guenego (A)

Department of Neuroradiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Nicolas Raposo (N)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Soren Christensen (S)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Lionel Calvière (L)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Alain Viguier (A)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Jean Darcourt (J)

Department of Neuroradiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Anne-Christine Januel (AC)

Department of Neuroradiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Michael Mlynash (M)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Agnes Sommet (A)

Clinical Investigation Center, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Claire Thalamas (C)

Clinical Investigation Center, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Igor Sibon (I)

Unité Neurovasculaire, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.

Vanessa Rousseau (V)

Clinical Investigation Center, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Thomas Tourdias (T)

Department of Neuroradiology, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.

Patrice Menegon (P)

Department of Neuroradiology, Centre Hospitalier Universitaire de Bordeaux, Université de Bordeaux, Bordeaux, France.

Fabrice Bonneville (F)

Department of Neuroradiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Mikael Mazighi (M)

Department of Interventional Neuroradiology, Hôpital Fondation A. de Rothschild, Paris, France.

Sylvain Charron (S)

Radiology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.

Laurence Legrand (L)

Radiology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.

Christophe Cognard (C)

Department of Neuroradiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Gregory W Albers (GW)

Stanford Stroke Center, Stanford University, Palo Alto, CA.

Jean-Claude Baron (JC)

Neurology Department, GHU Paris Psychiatrie et Neurosciences, Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM U1266, Université de Paris, FHU Neurovasc, Paris, France.

Jean-Marc Olivot (JM)

Acute Stroke Unit, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse and Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH